Can-Fite BioPharma Ltd. (NYSE: CANF), shares barely budged Monday as the biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory ...
The Namodenoson oral drug is well positioned in the field of anti-obesity agents due to its activity and favorable safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback